Fuzhi Song

Chief Executive Officer en GENEX PHARMACEUTICAL, INC. .

70 años

Health Technology

Perfil

Fuzhi Song is currently the Chairman, President & Chief Executive Officer at Genex Pharmaceutical, Inc. since 2004 and also the Chairman at Tianjin Zhongjin Biology Development Co. Ltd.
since 2003.
Previously, he was the Chief Executive Officer at Tianjin Zhongjin Pharmageutical Co. Ltd.
from 1998 to 1999 and Chairman at Tianjin Jinshi Group.

Cargos activos de Fuzhi Song

Empresas	Cargo	Inicio
GENEX PHARMACEUTICAL, INC.	Chief Executive Officer	-
Tianjin Zhongjin Biology Development Co. Ltd. Tianjin Zhongjin Biology Development Co. Ltd. Medical SpecialtiesHealth Technology Part of Genex Pharmaceutical, Inc., Tianjin Zhongjin Biology Development Co. Ltd. manufactures and distributes medical devices for healing broken bone injuries. The private company is based in Tianjin, China. Tianjin Zhongjin Biology Development Co. was acquired by Genex Pharmaceutical, Inc. on June 17, 2004 for $7.98 million.	Chairman	24/02/2010

Todos los cargos activos de Fuzhi Song

Antiguos cargos conocidos de Fuzhi Song.

Empresas	Cargo	Fin
Tianjin Zhongjin Pharmageutical Co. Ltd.	President	01/11/1999
Tianjin Jinshi Group	Chairman	01/01/1999

Ver el detalle de la experiencia de Fuzhi Song.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Fuzhi Song.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
GENEX PHARMACEUTICAL, INC.	Health Technology

Empresas privadas	3
Tianjin Zhongjin Biology Development Co. Ltd. Tianjin Zhongjin Biology Development Co. Ltd. Medical SpecialtiesHealth Technology Part of Genex Pharmaceutical, Inc., Tianjin Zhongjin Biology Development Co. Ltd. manufactures and distributes medical devices for healing broken bone injuries. The private company is based in Tianjin, China. Tianjin Zhongjin Biology Development Co. was acquired by Genex Pharmaceutical, Inc. on June 17, 2004 for $7.98 million.	Health Technology
Tianjin Zhongjin Pharmageutical Co. Ltd.
Tianjin Jinshi Group

Ver las conexiones de la empresa